for 11 straight years, but injuries and a suspension for using a banned substance have kept her off the courts for large chunks of the past four years. Her career earnings of $325 million from prize money, endorsements and appearances rank second all-time among women, behind her longtime adversary Serena Williams .
She continued to rack up sponsorship deals with Land Rover, PepsiCo and Sony coming on board. Nike introduced her line of tennis apparel, and her ballet flat was the best-selling shoe at former Nike subsidiary Cole Haan. in 2015 before her 2016 suspension for using meldonium, which had recently been added to the World Anti-Doping Agency’s list of banned substances. Sharapova said she had taken the drug for a decade because of a family history of diabetes. Her suspension was reduced from two years to 15 months on appeal.
Despite the doping ban, sponsors continued to gravitate to the tennis ace. She inked a multi-year deal with UBS shortly after her suspension ended, and Nike, Evian, Head and Porsche stuck with her.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »